Infection Control and Prevention Committee, Tokyo Teishin Hospital, 2-14-23 Fujimi, Chiyoda-ku, Tokyo, Japan.
J Infect Chemother. 2013 Apr;19(2):196-201. doi: 10.1007/s10156-012-0445-0. Epub 2012 Jul 18.
Nasal decolonization in methicillin-resistant Staphylococcus aureus (MRSA) carriers using mupirocin (MUP) is a strategy that complements barrier precautions and contact isolation. However, eradication failure cases have been observed despite isolates being susceptible to MUP. This would suggest that the minimum inhibitory concentration (MIC) alone is not the only determinant of successful eradication. In this study, we undertook a comparative analysis of MRSA isolates from cases of successful and unsuccessful MUP-eradication treatment. The analyses we carried out were: determination of mupirocin MICs, sequencing of the isoleucyl-tRNA synthetase (ileS) gene, staphylococcal cassette chromosome mec typing, and the assessment of slime production. MICs for all 14 of the successful nasal decolonization cases showed susceptibility to MUP, whereas 21 (87.5 %) of the 24 unsuccessful cases were MUP-susceptible, with low-level resistance seen in 3 (12.5 %) strains. In the analysis of mutations in the ileS gene, one strain with an MIC of 4 μg/ml exhibited a G1778A point mutation that has not been previously reported. In the 14 successful nasal decolonization cases, only 1 strain (7.1 %) was an MRSA slime-producer, compared with 19 (79.7 %) of the 24 MRSA strains that could not be eradicated after MUP treatment (p < 0.05). For the eradication of MRSA by MUP, it is possible that slime may affect drug penetration. In conclusion, slime production was the only significant difference between isolates recovered from successful and unsuccessful eradication cases.
耐甲氧西林金黄色葡萄球菌(MRSA)携带者使用莫匹罗星(MUP)进行鼻腔去定植是一种补充屏障预防和接触隔离的策略。然而,尽管分离株对 MUP 敏感,但仍观察到根除失败病例。这表明最低抑菌浓度(MIC)单独不是成功根除的唯一决定因素。在这项研究中,我们对成功和不成功的 MUP 根除治疗的 MRSA 分离株进行了对比分析。我们进行了以下分析:测定莫匹罗星 MIC 值、异亮氨酰-tRNA 合成酶(ileS)基因测序、葡萄球菌盒式染色体 mec 分型以及粘液产生评估。所有 14 例成功鼻腔去定植病例的 MIC 均显示对 MUP 敏感,而 24 例不成功病例中有 21 例(87.5%)对 MUP 敏感,3 例(12.5%)菌株表现出低水平耐药。在 ileS 基因突变分析中,1 株 MIC 为 4μg/ml 的菌株表现出以前未报道过的 G1778A 点突变。在 14 例成功的鼻腔去定植病例中,只有 1 株(7.1%)是 MRSA 粘液产生菌,而在 24 株经 MUP 治疗后无法根除的 MRSA 菌株中,有 19 株(79.7%)是粘液产生菌(p<0.05)。对于 MUP 根除 MRSA,粘液可能会影响药物渗透。总之,粘液产生是从成功和不成功根除病例中分离出的分离株之间唯一的显著差异。